Secondary Logo

Journal Logo

Articles by Susan B. Bressler, MD

ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND RISK OF TRACTION RETINAL DETACHMENT IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY: Pooled Analysis of Five DRCR Retina Network Randomized Clinical Trials

Bressler, Neil M.; Beaulieu, Wesley T.; Bressler, Susan B.; More

RETINA. ., Post Author Corrections: September 17, 2019

PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Should Baseline Characteristics Affect Choice of Treatment?

Bressler, Susan B.; Beaulieu, Wesley T.; Glassman, Adam R.; More

RETINA. 39(9):1646-1654, September 2019.

CHANGES IN DIABETIC RETINOPATHY SEVERITY WHEN TREATING DIABETIC MACULAR EDEMA WITH RANIBIZUMAB: DRCR.net Protocol I 5-Year Report

Bressler, Susan B.; Odia, Isoken; Glassman, Adam R.; More

RETINA. 38(10):1896-1904, October 2018.

EFFECTIVENESS OF DIFFERENT MONITORING MODALITIES IN THE DETECTION OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: The Home Study, Report Number 3

Chew, Emily Y.; Clemons, Traci E.; Harrington, Molly; More

RETINA. 36(8):1542-1547, August 2016.

RANIBIZUMAB PLUS PROMPT OR DEFERRED LASER FOR DIABETIC MACULAR EDEMA IN EYES WITH VITRECTOMY BEFORE ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY

Bressler, Susan B.; Melia, Michele; Glassman, Adam R.; More

RETINA. 35(12):2516-2528, December 2015.

RANIBIZUMAB FOR MACULAR TELANGIECTASIA TYPE 2 IN THE ABSENCE OF SUBRETINAL NEOVASCULARIZATION

Do, Diana V.; Bressler, Susan B.; Cassard, Sandra D.; More

Retina. 34(10):2063-2071, October 2014.

GREEN OR YELLOW LASER TREATMENT FOR DIABETIC MACULAR EDEMA: Exploratory Assessment Within the Diabetic Retinopathy Clinical Research Network

Bressler, Susan B.; Almukhtar, Talat; Aiello, Lloyd P.; More

Retina. 33(10):2080-2088, November/December 2013.

EFFECT OF FOCAL/GRID PHOTOCOAGULATION ON VISUAL ACUITY AND RETINAL THICKENING IN EYES WITH NON–CENTER-INVOLVED DIABETIC MACULAR EDEMA

SCOTT, INGRID U.; DANIS, RONALD P.; BRESSLER, SUSAN B.; More

Retina. 29(5):613-617, May 2009.

ASSOCIATION OF THE EXTENT OF DIABETIC MACULAR EDEMA AS ASSESSED BY OPTICAL COHERENCE TOMOGRAPHY WITH VISUAL ACUITY AND RETINAL OUTCOME VARIABLES

BROWNING, DAVID J.; APTE, RAJENDRA S.; BRESSLER, SUSAN B.; More

Retina. 29(3):300-305, March 2009.

A Randomized Trial Comparing Intravitreal Triamcinolone and Focal/Grid Photocoagulation for Diabetic Macular Edema: Baseline Features

Ip, Michael S.; Bressler, Susan B.; Antoszyk, Andrew N.; More

Retina. 28(7):919-930, July-August 2008.

AGREEMENT BETWEEN CLINICIAN AND READING CENTER GRADINGS OF DIABETIC RETINOPATHY SEVERITY LEVEL AT BASELINE IN A PHASE 2 STUDY OF INTRAVITREAL BEVACIZUMAB FOR DIABETIC MACULAR EDEMA

SCOTT, INGRID U.; BRESSLER, NEIL M.; BRESSLER, SUSAN B.; More

Retina. 28(1):36-40, January 2008.

PATIENTS’ PREFERENCES IN CHOOSING THERAPY FOR RETINAL VEIN OCCLUSIONS

CHANG, MARGARET A.; FINE, HOWARD F.; BASS, ERIC; More

Retina. 27(6):789-797, July-August 2007.

BILATERAL IDIOPATHIC MULTIFOCAL RETINAL PIGMENT EPITHELIUM DETACHMENTS IN OTHERWISE HEALTHY MIDDLE-AGED ADULTS: A Clinicopathologic Study

GASS, J DONALD M.; BRESSLER, SUSAN B.; AKDUMAN, LEVENT; More

Retina. 25(3):304-310, April-May 2005.

CHANGES IN LESION SIZE AFTER SUBMACULAR SURGERY FOR SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN THE SUBMACULAR SURGERY TRIALS PILOT STUDY

SADDA, SRINIVAS R.; PIERAMICI, DANTE J.; MARSH, MARTA J.; More

Retina. 24(6):888-899, December 2004.

RETROSPECTIVE CASE SERIES OF JUXTAFOVEAL CHOROIDAL NEOVASCULARIZATION TREATED WITH PHOTODYNAMIC THERAPY WITH VERTEPORFIN

BLAIR, MICHAEL P.; APTE, RAJENDRA S.; MISKALA, PÄIVI H.; More

Retina. 24(4):501-506, August 2004.

Show: